Experience with Thymoglobulin® induction therapy in pancreas transplant recipients.

被引：0
|
作者：
Wiland, AM
Fink, JC
Philosophe, B
Farney, AC
Schweitzer, EJ
Colonna, JO
Weir, MR
Bartlett, ST
机构：
[1] Univ Maryland, Sch Med, Dept Pharm Serv, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Div Nephrol, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA
来源：
TRANSPLANTATION | 2000年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1136
引用
收藏
页码：S408 / S408
页数：1
相关论文
共 50 条
  • [1] Cost effective measures to administer Thymoglobulin® for induction therapy in pancreas transplant recipients.
    Wiland, AM
    Fink, JC
    Philosophe, B
    Farney, A
    Schweitzer, EJ
    Colonna, JO
    Weir, MR
    Bartlett, ST
    TRANSPLANTATION, 2000, 69 (08) : S408 - S408
  • [2] Perioperative thymoglobulin induction in paediatric heart transplant recipients.
    Dipchand, A. I.
    Allain-Rooney, T.
    Babu, A.
    Pollock-Barziv, S. M.
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 53 - 53
  • [3] Safety of thymoglobulin induction in HCV liver transplant recipients.
    Bajjoka, Iman
    Hsaiky, Lama
    Brown, Kimberly
    Abouljoud, Marwan
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 164 - 164
  • [4] Clinical experience with repeated courses of thymoglobulin for induction and for treatment of rejection in renal transplant recipients.
    Lo, A
    Olson, B
    Gaber, LW
    Gaber, AO
    PHARMACOTHERAPY, 2003, 23 (03): : 413 - 413
  • [5] Thymoglobulin is less expensive and as effective as ATGam for induction therapy in pediatric renal transplant recipients.
    Durand, BJ
    Matas, A
    Ingulli, E
    TRANSPLANTATION, 2000, 69 (08) : S306 - S306
  • [6] Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience
    Trofe, J
    Stratta, RJ
    Egidi, MF
    Lo, A
    Gaber, LW
    Shokouh-Amiri, MH
    Grewal, HP
    Honaker, M
    Hardinger, K
    Alloway, RR
    Gaber, AO
    CLINICAL TRANSPLANTATION, 2002, 16 : 34 - 44
  • [7] A Pharmacoeconomic Analysis of Alemtuzumab Versus Thymoglobulin Induction in Renal Transplant Recipients.
    Tseng, Christine Y.
    Truscott, Christie B.
    Zavala, Edward
    Feurer, Irene
    Shaffer, David
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 370 - 370
  • [8] Thymoglobulin (ATG) induction in high-risk kidney transplant recipients.
    Gurk-Turner, Cheryle
    Philosophe, Benjamin
    Airee, Richa
    Owens, Elizabeth
    Jackson, L. Andrew
    Kukuruga, Debra
    Haririan, Abdolreza
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 522 - 523
  • [9] Use of thymoglobulin for induction immunosuppression in living unrelated kidney transplant recipients.
    Wong, WC
    Agrawal, N
    Pascual, M
    DelVecchio, AM
    Doran, MT
    Anderson, D
    Hirsh, H
    Delmonico, FL
    Cosimi, AB
    Tolkoff-Rubin, N
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 442A - 442A
  • [10] Thymoglobulin induction therapy does not increase risk of BK virus replication in kidney transplant recipients.
    Wong, WC
    Hirsch, HH
    Fujimoto, K
    Pascual, M
    Doran, MT
    Delvecchio, AM
    Cosimi, AB
    Tolkoff-Rubin, N
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 197 - 197
12345